A Double-Blind, Randomized, Placebo-Controlled Phase I/II Study to Evaluate the Safety of an Intravaginal Matrix Ring With Dapivirine in Healthy, HIV-Negative Women.
Phase of Trial: Phase I/II
Latest Information Update: 08 Mar 2012
At a glance
- Drugs Dapivirine (Primary)
- Indications HIV infections
- Focus Adverse reactions
- 08 Mar 2012 Results presented at the 19th Conference on Retroviruses and Opportunistic Infections.
- 01 Aug 2011 Actual end date (July 2011) added as reported by ClinicalTrials.gov.
- 01 Aug 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.